Pre-Operative Staging of Pancreatic Cancer Using Superparamagnetic Iron Oxide Magnetic Resonance Imaging (SPIO MRI)
Status:
Completed
Trial end date:
2013-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this research study is to see if a specific kind of MRI, called Ultrasmall
Superparamagnetic Iron Oxide Magnetic Resonance Imaging (USPIO MRI), which uses an
FDA-approved therapeutic agent(Feraheme) to see if it is able to identify small and otherwise
undetectable lymph node metastases in people who have pancreatic cancer and are scheduled for
surgical resection.